| |
|
|
SAN FRANCISCO -
EOS, a private genomic research company, will relocate from its 31,000-sf space in South San Francisco, to a 82,000-sf building at Slough Estates USA's $250 million development at Oyster Point. Construction of the facility is scheduled to begin in July 2001.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more! Sign Up Now!
|
|
Printer Friendly Version
Send to a Friend
